Upgrades Neutral Outperform X

ICLR ICON plc

Robert W. Baird

$224

Downgrades Overweight Neutral X

ICLR ICON plc

JP Morgan

$150

Downgrades Buy Hold X

ICLR ICON plc

TD Cowen

$157

Downgrades Overweight Eq Weight X

ICLR ICON plc

Barclays

$165

Downgrades Buy Neutral X

ICLR ICON plc

Goldman

$250 $200

Initiated Outperform X

ICLR ICON plc

RBC Capital Mkts

$263

Downgrades Outperform Neutral X

ICLR ICON plc

Robert W. Baird

$340

Initiated Neutral X

ICLR ICON plc

Redburn Atlantic

Initiated Outperform X

ICLR ICON plc

Leerink Partners

$379

Initiated Buy X

ICLR ICON plc

Goldman

$370

Initiated Buy X

ICLR ICON plc

Truist

$357

Initiated Outperform X

ICLR ICON plc

TD Cowen

$306

Upgrades Eq Weight Overweight X

ICLR ICON plc

Barclays

$215 $260

Upgrades Eq Weight Overweight X

ICLR ICON plc

Barclays

Upgrades Neutral Buy X

ICLR ICON plc

BofA Securities

$265 $260

Initiated Buy X

ICLR ICON plc

UBS

$270

Initiated Neutral X

ICLR ICON plc

Credit Suisse

$260

Initiated Buy X

ICLR ICON plc

Guggenheim

$285

Downgrades Overweight Eq Weight X

ICLR ICON plc

Wells Fargo

$250

Upgrades Hold Buy X

ICLR ICON plc

Deutsche Bank

$234 $310

Upgrades Neutral Buy X

ICLR ICON plc

Citigroup

$260

Initiated Neutral X

ICLR ICON plc

Citigroup

$220

Resumed Neutral X

ICLR ICON plc

BofA Securities

$220

Upgrades Eq Weight Overweight X

ICLR ICON plc

Wells Fargo

$200 $235

Upgrades Neutral Outperform X

ICLR ICON plc

Robert W. Baird

$215

Initiated Equal Weight X

ICLR ICON plc

Barclays

$200

Upgrades Neutral Buy X

ICLR ICON plc

UBS

$207 $232

Upgrades Hold Buy X

ICLR ICON plc

Truist

$280

Upgrades Sell Neutral X

ICLR ICON plc

UBS

Upgrades Neutral Buy X

ICLR ICON plc

Mizuho

Upgrades In-line Outperform X

ICLR ICON plc

Evercore ISI

Initiated Sell X

ICLR ICON plc

UBS

Downgrades Outperform In-line X

ICLR ICON plc

Evercore ISI

Reiterated Neutral X

ICLR ICON plc

Mizuho

$109 $114

ICLR  ICON plc

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.